Mark Strobeck

Mark Strobeck is President, Chief Executive Officer & Director at Rockwell Medical, Inc. since 2022.
Dr. Strobeck is Chairman at Windtree Therapeutics, Inc. starting in 2025.
Dr. Strobeck is Director at Horse Power For Life since 2012.
Former roles include President, Chief Executive Officer & Director at Corridor Pharmaceuticals, Inc. from 2012 to 2013; Managing Director at Aquilo Partners LP from 2021 to 2022; Chief Operating Officer & Executive Vice President at Assertio Therapeutics, Inc. in 2020; Chief Operating Officer & Executive Vice President at Zyla Life Sciences LLC from 2015 to 2020; Chief Business Officer & Vice President at Topaz Pharmaceuticals, Inc. from 2010 to 2011; Principal at GSK Equity Investments Ltd. from 2004 to 2006; Vice President-Business Development at GlaxoSmithKline, Inc. from 2003 to 2008; Chief Business Officer at Trevena, Inc. from 2008 to 2010.
Other former positions include Director at Novalar Pharmaceuticals, Inc. and Protein Forest, Inc.; Board Observer at Standard BioTools, Inc., Santarus, Inc., and KuDOS Pharmaceuticals Ltd.; Principal at Tanabe Pharma Corp.; Member at Ben Franklin Technology Partners; Chief Operating Officer & Executive Vice President at Assertio Holdings, Inc. Education includes a doctorate from the University of Cincinnati (Ohio) conferred in 1999 and an undergraduate degree from St. Lawrence University conferred in 1993.